---
title: "EUDA Health Announces Collaboration to Advance an Integrated iPSC Cell Therapy Program for Oncology and Wellness  •  Targets global distribution for innovative Oncology products"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294343335.md"
description: "Singapore-based EUDA Health Holdings Limited (NASDAQ: EUDA) shared detailed information about the integrated cell therapy program planned under its latest non-binding Memorandum of Understanding (MOU) with GO POSB Organoids Pte Ltd (“GO POSB”) and Shenzhen Innovation Immunotechnology Co., Ltd. The program aims to distribute wellness and healthcare products and services in Asia, focusing on Singapore, Malaysia, and China. EUDA Health Holdings Limited specializes in third-party provided non-invasive solutions."
datetime: "2026-07-30T10:02:24.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294343335.md)
  - [en](https://longbridge.com/en/news/294343335.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294343335.md)
generator: "portal-rs"
---

# EUDA Health Announces Collaboration to Advance an Integrated iPSC Cell Therapy Program for Oncology and Wellness  •  Targets global distribution for innovative Oncology products

Singapore-based EUDA Health Holdings Limited (NASDAQ: EUDA) shared detailed information about the integrated cell therapy program planned under its latest non-binding Memorandum of Understanding (MOU) with GO POSB Organoids Pte Ltd (“GO POSB”) and Shenzhen Innovation Immunotechnology Co., Ltd. The program aims to distribute wellness and healthcare products and services in Asia, focusing on Singapore, Malaysia, and China. EUDA Health Holdings Limited specializes in third-party provided non-invasive solutions.

### Related Stocks

- [EUDA.US](https://longbridge.com/en/quote/EUDA.US.md)
- [EUDAW.US](https://longbridge.com/en/quote/EUDAW.US.md)

## Related News & Research

- [EUDA Health signs MOU with GO POSB, SIIT to develop off-the-shelf iPSC cell therapies](https://longbridge.com/en/news/294340008.md)
- [NVCT: Strong clinical progress and financial position drive near-term catalysts in precision medicine](https://longbridge.com/en/news/298760060.md)
- [EXCLUSIVE-TPG explores $5 billion sale of healthcare software company Lyric, sources say](https://longbridge.com/en/news/298497579.md)
- [Echo Real Estate Capital forms programmatic joint venture with Belay Investment Group for value-add medical office deals](https://longbridge.com/en/news/298628293.md)
- [Volatile yen risks 'confused' global markets, chairman of Japanese shipping giant says](https://longbridge.com/en/news/298422074.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**